ProfileGDS4177 / 219076_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 73% 76% 87% 90% 83% 85% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated119.3173
GSM603099KU-812 non-treated159.8876
GSM603098KCL-22 Imatinib-treated386.3487
GSM603097KCL-22 non-treated516.0290
GSM603102JURL-MK1 Imatinib-treated267.4283
GSM603101JURL-MK1 non-treated324.9785